Olaplex (NASDAQ:OLPX) Insider Trisha Fox Sells 25,421 Shares of Stock

Olaplex Holdings, Inc. (NASDAQ:OLPX) insider Trisha Fox sold 25,421 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $1.26, for a total transaction of $32,030.46. Following the sale, the insider owned 1,080,363 shares of the company’s stock, valued at approximately $1,361,257.38. The trade was a 2.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Olaplex Stock Performance

Olaplex stock traded up $0.05 during trading on Monday, hitting $1.25. The stock had a trading volume of 1,389,925 shares, compared to its average volume of 1,790,682. The stock’s 50 day moving average is $1.54 and its two-hundred day moving average is $1.36. Olaplex Holdings, Inc. has a 1 year low of $0.99 and a 1 year high of $1.84. The stock has a market cap of $836.75 million, a price-to-earnings ratio of -125.00 and a beta of 2.24. The company has a quick ratio of 4.00, a current ratio of 4.58 and a debt-to-equity ratio of 0.40.

Olaplex (NASDAQ:OLPX) last released its earnings results on Thursday, March 5th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.01. The business had revenue of $105.12 million during the quarter, compared to the consensus estimate of $104.21 million. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period last year, the business posted $0.01 earnings per share. As a group, analysts predict that Olaplex Holdings, Inc. will post 0.1 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on OLPX shares. Barclays set a $1.75 target price on Olaplex in a research note on Friday, January 16th. Morgan Stanley set a $1.40 price objective on shares of Olaplex in a research note on Tuesday, March 10th. Northland Securities initiated coverage on shares of Olaplex in a research note on Thursday, November 20th. They issued an “outperform” rating and a $2.00 target price on the stock. Telsey Advisory Group restated a “market perform” rating and set a $2.00 price target on shares of Olaplex in a research report on Monday, March 2nd. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Olaplex in a research report on Wednesday, March 4th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Olaplex presently has an average rating of “Hold” and an average price target of $1.88.

Institutional Trading of Olaplex

Several institutional investors and hedge funds have recently made changes to their positions in OLPX. Fund 1 Investments LLC purchased a new position in Olaplex in the fourth quarter worth $1,023,000. Abel Hall LLC purchased a new stake in Olaplex during the fourth quarter valued at about $27,000. Jump Financial LLC lifted its stake in Olaplex by 193.7% during the fourth quarter. Jump Financial LLC now owns 29,800 shares of the company’s stock worth $40,000 after purchasing an additional 19,653 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Olaplex by 284.7% in the 4th quarter. Russell Investments Group Ltd. now owns 1,909,836 shares of the company’s stock worth $2,559,000 after purchasing an additional 1,413,423 shares in the last quarter. Finally, Barclays PLC boosted its holdings in shares of Olaplex by 9.5% in the 4th quarter. Barclays PLC now owns 245,088 shares of the company’s stock worth $328,000 after purchasing an additional 21,292 shares in the last quarter. Hedge funds and other institutional investors own 87.37% of the company’s stock.

About Olaplex

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.